Table 1 Clinical characters of RLPS for prognostic analysis using cutoff value of MTV
Parameters | n | MTV > 457.65 (95% CI) | MTV < 456.65 (95% CI) | P-value | Odds Ratio (95% CI) | |
|---|---|---|---|---|---|---|
Age(y) | 54.85 ± 10.07 (47.42, 58.21) | 54.73 ± 10.48 (52.40, 58.35) | 0.784 | — | ||
Operative time (min) | 606.10 ± 198.81 (456.51, 657.86) | 470.19 ± 163.69 (429.57, 525.30) | 0.083 | — | ||
Blood loss (ml) | 3320.00 ± 2797.67 (1182.93, 3867.07) | 1799.23 ± 1869.47 (1356.35, 2462.82) | 0.014 | — | ||
Gender | 0.612 | 1.31 (0.46–3.72) | ||||
Male | 43 (59.7%) | 11 (15.3%) | 32 (44.4%) | |||
Female | 29 (40.3%) | 9 (12.5%) | 20 (27.8%) | |||
Tumor size (cm) | 29.68 ± 15.59 (19.20, 35.37) | 20.80 ± 9.93 (18.00, 23.57) | 0.141 | — | ||
Pathological subtype | 0.069 | |||||
WDLPS | 17 (23.6%) | 1 (1.4%) | 16 (22.2%) | — | ||
DDLPS | 44 (61.1%) | 15 (29.4%) | 29 (40.3%) | 9.14 (0.86–97.27) | ||
PLPS | 11 (15.3%) | 4 (5.6%) | 7 (9.7%) | 8.28 (0.99–68.55) | ||
Histological grade (FNCLCC) | 0.24 | |||||
G1 | 19 (26.4%) | 3 (4.2%) | 16 (22.2%) | — | ||
G2 | 33 (45.8%) | 9 (12.5%) | 24 (33.3%) | 2.00 (0.47–8.54) | ||
G3 | 20 (27.8%) | 8 (11.1%) | 12 (16.7%) | 3.56 (0.78–16.31) | ||
Complication (Dindo–Clavien Classification) | 0.635 | |||||
I | 31 (43.1%) | 7 (9.7%) | 24 (33.3%) | — | ||
II | 29 (40.3%) | 8 (11.1%) | 21 (29.2%) | 1.31 (0.41–4.21) | ||
IIIa | 9 (12.5%) | 4 (5.6%) | 5 (6.9%) | 2.74 (0.58–13.07) | ||
IIIb | 3 (4.2%) | 1 (1.4%) | 2 (2.8%) | 1.71 (0.14–21.82) | ||
Length of stay (days) | 37.00 ± 12.04 (29.73, 42.90) | 29.92 ± 15.43 (25.74, 34.96) | 0.664 | — | ||
Resection of organs | 7.65 ± 3.84 (5.32, 9.18) | 5.90 ± 2.58 (5.24, 6.76) | 0.007 | — | ||
Multifocal disease | 0.151 | 2.22 (0.74–6.70) | ||||
Yes | 20 (27.8%) | 8 (11.1%) | 12 (16.7%) | |||
No | 52 (72.2%) | 12 (16.7%) | 40 (55.6%) | |||
Vascular resection | 0.863 | 1.11 (0.34–3.69) | ||||
Yes | 17 (23.9%) | 5 (6.9%) | 12 (16.7%) | |||
No | 55 (76.4%) | 15 (20.8%) | 40 (55.6%) | |||
Organs invaded by | 2.19±1.72 | 1.08±1.09 | 0.159 | – | ||
sarcoma | (1.27, 3.10) | (0.77, 1.40) |